Continuous Glucose Monitoring in Pediatric Diabetic Ketoacidosis
Authors' conclusion
Continuous glucose monitoring use in inpatient pediatric DKA treatment was found to be feasible and reliable.
Study context
- Population
- Children admitted to the paediatric ICU for diabetic ketoacidosis (DKA); mean ± SD age 11.9 ± 4.1 years
- Participants
- 35 children
- Comparison
- Real-time continuous glucose monitoring (rtCGM) vs point-of-care (POC) capillary and serum glucose
- Outcome
- Accuracy of rtCGM glucose vs POC capillary and serum glucose during standard DKA treatment, by Clarke Error Grid analysis
Methodological detailssingle-arm, single-centre
- Single-arm
- Single-centre
Performance
As reported in the abstract
Clarke Error Grid: matched pairs in clinically acceptable A + B zones
CGM/POC pairs in A + B zones (of 524 matched pairs)
95.4%
CGM/serum glucose pairs in A + B zones (of 91 matched pairs)
95.6%
Secondary outcomes
Mean LOS
- Average LOS (mean ± SD)
- 1.32 ± 0.73 days
Relationship between rtCGM readings and degree of acidosis
- Serum bicarbonate level did not appear to affect the accuracy of rtCGM in DKA
Original publication
Continuous Glucose Monitoring in Pediatric Diabetic Ketoacidosis. J Diabetes Sci Technol. Published 23 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →